NASDAQ : ARCT

Arcturus Therapeutics Holdings Inc. — Financial statements

Healthcare · Biotechnology · United States

Last price 9.93 USD (Nov 2, 2026, 12:21 PM EST) · Market cap 282.24M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

Arcturus Therapeutics Holdings Inc. (ARCT) reported revenue of 29.37M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue29.37M82.03M152.31M166.80M206.00M12.36M
Cost of Revenue86.78M112.21M195.16M192.13M147.75M173.76M
Gross Profit-57.41M-30.18M-42.85M-25.33M58.25M-161.40M
Selling, General & Admin44.88M46.08M52.82M52.87M46.07M41.45M
Operating Expenses44.88M46.08M52.82M52.87M46.07M41.45M
Operating Income-102.29M-76.26M-95.67M-78.20M12.18M-202.85M
Interest Expense-9.00K-9.00K
Interest & Investment Income8.52M10.10M15.20M16.59M
Earnings From Equity Investments-515.00K515.00K
Currency Exchange Gain (Loss)382.00K382.00K-471.00K-229.00K-598.00K584.00K
Other Non Operating Income (Expenses)125.00K-420.00K-1.92M
EBT Excluding Unusual Items-93.28M-65.78M-80.94M-61.84M10.64M-203.67M
Other Unusual Items33.95M
Pretax Income-93.28M-65.78M-80.94M-27.89M10.64M-203.67M
Income Tax Expense-4.00K-4.00K1.83M1.29M
Net Income-93.28M-65.78M-80.94M-29.73M9.35M-203.67M
Net Income to Common-93.28M-65.78M-80.94M-29.73M9.35M-203.67M
Shares Outstanding (Basic)28.04M27.39M27.00M26.63M26.45M26.32M
Shares Outstanding (Diluted)28.04M27.39M27.00M26.63M27.09M26.32M
EPS (Basic)-3.33-2.40-3.00-1.120.35-7.74
EPS (Diluted)-3.33-2.40-3.00-1.120.35-7.74
Free Cash Flow-72.82M-74.50M-60.40M-21.00M24.27M-138.45M
Free Cash Flow Per Share-2.60-2.72-2.24-0.790.90-5.26
Gross Margin-195.50%-36.79%-28.13%-15.19%28.28%
Operating Margin-348.32%-92.97%-62.81%-46.89%5.91%-1,641.33%
Profit Margin-317.61%-80.19%-53.14%-17.82%4.54%-1,647.98%
Free Cash Flow Margin-247.96%-90.82%-39.65%-12.59%11.78%-1,120.23%
EBITDA-99.55M-73.23M-92.12M-75.25M13.70M-201.66M
EBITDA Margin-89.28%-60.48%-45.11%6.65%
D&A For EBITDA2.75M3.02M3.54M2.96M1.53M1.19M
EBIT-102.29M-76.26M-95.67M-78.20M12.18M-202.85M
EBIT Margin-92.97%-62.81%-46.89%5.91%
Effective Tax Rate12.17%
Revenue as Reported29.37M82.03M152.31M166.80M206.00M12.36M

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents191.48M230.91M237.03M292.00M391.88M370.49M
Cash & Short-Term Investments191.48M230.91M237.03M292.00M391.88M370.49M
Receivables1.81M5.56M3.97M32.06M2.76M3.37M
Prepaid Expenses3.87M4.97M9.98M7.52M8.69M5.10M
Restricted Cash55.00M55.00M
Total Current Assets197.16M241.45M305.98M386.59M403.33M378.96M
Property, Plant & Equipment25.12M27.82M36.20M40.93M44.96M11.26M
Long-Term Investments515.00K
Other Long-Term Assets2.03M1.89M1.89M1.89M2.09M2.08M
Total Assets224.31M271.15M344.07M429.40M450.39M392.81M
Accounts Payable4.41M4.24M7.19M5.28M7.45M10.06M
Accrued Expenses13.00M13.29M25.36M16.78M17.59M19.21M
Current Portion of Long-Term Debt60.66M22.47M
Current Portion of Leases3.97M4.21M3.55M4.31M3.88M1.54M
Current Income Taxes Payable641.00K1.29M
Current Unearned Revenue6.28M8.25M21.93M47.34M36.12M43.48M
Other Current Liabilities5.88M6.39M7.44M7.63M2.78M
Total Current Liabilities33.54M36.38M65.49M81.99M126.98M99.54M
Long-Term Debt40.63M
Long-Term Leases18.97M20.78M25.00M25.91M30.22M4.50M
Long-Term Unearned Revenue12.60M42.50M20.07M19.93M
Other Long-Term Liabilities497.00K2.80M
Total Liabilities52.50M57.16M103.09M150.89M180.07M164.60M
Common Stock28.00K28.00K27.00K27.00K27.00K26.00K
Additional Paid-In Capital737.12M728.55M689.76M646.35M608.43M575.67M
Retained Earnings-565.34M-514.59M-448.81M-367.87M-338.14M-347.49M
Shareholders' Equity171.81M213.99M240.98M278.51M270.31M228.21M
Total Liabilities & Equity224.31M271.15M344.07M429.40M450.39M392.81M
Total Debt22.93M25.00M28.55M30.22M94.75M69.15M
Net Cash (Debt)168.55M205.91M208.48M261.79M297.13M301.35M
Net Cash Per Share6.017.527.729.8310.9711.45
Filing Date Shares Outstanding28.42M28.42M27.12M26.92M26.56M26.38M
Total Common Shares Outstanding28.42M28.41M27.10M26.83M26.55M26.37M
Working Capital163.62M205.07M240.49M304.60M276.35M279.42M
Book Value Per Share6.047.538.8910.3810.188.65
Tangible Book Value171.81M213.99M240.98M278.51M270.31M228.21M
Tangible Book Value Per Share6.047.538.8910.3810.188.65
Machinery15.64M16.61M18.70M18.28M12.36M7.80M
Construction In Progress233.00K3.34M2.06M
Leasehold Improvements2.60M2.61M2.64M2.65M2.49M44.00K

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income-93.28M-65.78M-80.94M-29.73M9.35M-203.67M
Depreciation & Amortization2.75M3.02M3.54M2.96M1.53M1.19M
Loss (Gain) From Sale of Assets20.00K
Asset Writedown & Restructuring Costs1.90M1.90M5.00M
Loss (Gain) on Equity Investments515.00K-515.00K
Stock-Based Compensation21.10M25.41M37.99M34.65M30.61M28.91M
Other Operating Activities241.00K382.00K471.00K-33.36M2.55M1.41M
Change in Accounts Receivable15.39M-1.59M28.09M-29.30M603.00K-1.24M
Change in Accounts Payable-6.21M-2.96M1.92M-2.24M-3.11M-769.00K
Change in Unearned Revenue-13.76M-23.87M-55.21M38.61M-14.69M32.79M
Change in Other Net Operating Assets-885.00K-10.78M4.39M313.00K4.65M1.84M
Operating Cash Flow-72.73M-74.27M-59.75M-18.10M31.99M-135.04M
Capital Expenditures-93.00K-230.00K-648.00K-2.90M-7.73M-3.41M
Sale of Property, Plant & Equipment52.00K
Investing Cash Flow-41.00K-230.00K-648.00K-2.90M-7.73M-3.41M
Long-Term Debt Issued15.00M20.00M46.60M
Long-Term Debt Repaid-15.00M-47.36M-5.00M
Net Debt Issued (Repaid)-27.36M-5.00M46.60M
Issuance of Common Stock12.93M13.38M5.42M3.28M2.14M1.42M
Financing Cash Flow12.93M13.38M5.42M-24.09M-2.86M48.02M
Net Cash Flow-59.84M-61.12M-54.98M-45.09M21.41M-90.43M
Free Cash Flow-72.82M-74.50M-60.40M-21.00M24.27M-138.45M
Free Cash Flow Margin-247.96%-90.82%-39.65%-12.59%11.78%-1,120.23%
Free Cash Flow Per Share-2.60-2.72-2.24-0.790.90-5.26
Levered Free Cash Flow19.26M9.18M-9.02M-82.07M15.96M-74.77M
Unlevered Free Cash Flow19.26M9.18M-9.02M-82.07M15.96M-74.77M
Cash Interest Paid2.13M813.00K684.00K
Cash Income Tax Paid1.41M
Change in Working Capital-5.46M-39.20M-20.81M7.38M-12.56M32.62M

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization313.51M174.18M459.67M842.59M450.38M975.60M
Enterprise Value144.96M19.81M251.92M581.89M307.45M628.97M
Last Close Price11.036.1316.9731.5316.9637.01
PE Ratio48.17
Forward PE118.08118.08118.08118.084.34
PS Ratio10.682.123.025.052.1978.94
PB Ratio1.820.811.913.021.674.28
P/TBV Ratio1.820.811.913.021.674.28
P/FCF Ratio18.56
P/OCF Ratio14.08
EV/Sales Ratio4.940.241.653.491.4950.89
EV/EBITDA Ratio22.43
EV/EBIT Ratio25.25
EV/FCF Ratio12.67
Debt / Equity Ratio0.130.120.120.110.350.30
Debt / EBITDA Ratio5.15
Debt / FCF Ratio3.90
Net Debt / Equity Ratio-0.98-0.96-0.86-0.94-1.10-1.32
Net Debt / EBITDA Ratio1.692.812.263.48-21.681.49
Net Debt / FCF Ratio2.312.763.4512.47-12.242.18
Asset Turnover0.110.270.390.380.490.03
Quick Ratio5.766.503.683.953.113.76
Current Ratio5.886.644.674.713.183.81
Return on Equity (ROE)-46.31%-28.92%-31.16%-10.83%3.75%-65.20%
Return on Assets (ROA)-23.96%-15.49%-15.46%-11.11%1.80%-29.17%
Return on Invested Capital (ROIC)-388.71%-467.62%
Return on Capital Employed (ROCE)-53.60%-32.50%-34.30%-22.50%3.80%-69.20%
Earnings Yield-30.16%-37.77%-17.61%-3.53%2.08%-20.88%
FCF Yield-23.23%-42.77%-13.14%-2.49%5.39%-14.19%
Buyback Yield / Dilution-3.47%-1.43%-1.40%1.72%-2.95%-29.61%